Roche aims to recruit a diverse population across 17 countries in new phase III study. Pharma giant Roche and its subsidiary Genentech...

The healthcare company said that further analysis to better understand safety data from these trials is continuing. GSK, the British...

Merck and Eisai add potent new weapon to the pharma battle for kidney cancer supremacy. On Wednesday, the Food and Drug Administration...

The fast-track designation for older populations highlights the critical need for an RSV vaccine. The American-based biotech, which made...